The effects of ezetimibe/simvastatin versus simvastatin monotherapy on platelet and inflammatory biomarkers in patients with metabolic syndrome

Cardiology (Switzerland)

Volumn 125, Issue 2, 2013, Pages 74-77

  Miller, Michael ^a   Dinicolantonio, James J ^b   Can, Mehmet ^b   Grice, Rachel ^a   Damoulakis, Abigail ^a   Serebruany, Victor L ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Biomarkers; Ezetimibe; Inflammation; Metabolic syndrome; Platelets; Simvastatin

Indexed keywords

APOLIPOPROTEIN B; BETA3 INTEGRIN; BIOLOGICAL MARKER; CD31 ANTIGEN; CD51 ANTIGEN; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; THROMBOMODULIN; TRIACYLGLYCEROL; VITRONECTIN RECEPTOR;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MONOTHERAPY; PLATELET REACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 84877651595     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000347134     Document Type: Article

References (14)

1. Serebruany VL, Miller M, Pokov AN, Malinin AI, Lowry DR, Tanguay J-F, Hennekens CH: Statins inhibit platelet PAR-1 thrombin receptor in patients with metabolic syndrome: the PAR-1 Inhibition by Statins (PARIS) Study. Am J Cardiol 2006; 79: 1332-1336.
2. Palomo I, Moore-Carrasco R, Alarcon M, Rojas A, Espana F, Andres V, Gonzalez-Navarro H: Pathophysiology of the proatherothrombotic state in the metabolic syndrome. Front Biosci 2010; 2: 194-208.
3. Swislocki AL, Siegel D, Jialal I: Pharmacotherapy for the metabolic syndrome. Curr Vasc Pharmacol 2012; 10: 187-205.
4. Joy TR, Hegele RA: Narrative review: statinrelated myopathy. Ann Intern Med 2009; 150: 858-868.
5. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 2001; 285: 2486-2497.
6. Miller M, Beach V, Sorkin JD, Mangano C, Dobmeier C, Novacic D, Rhyne J, Vogel RA: Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance. J Am Diet Assoc 2009; 109: 713-717.
7. Undas A, Machnik A, Potaczek DP, Wypasek E, Zmudka K, Tracz W: Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary events. J Cardiovasc Pharmacol 2011; 58: 167-172.
8. Krysiak R, Zmuda W, Okopien B: The effect of ezetimibe, administered alone or in combination with simvastatin, on lymphocyte cytokine release in patients with elevated cholesterol levels. J Intern Med 2012; 271: 32-42.
9. Woodfin A, Voisin MB, Nourshargh S: PECAM- 1: a multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol 2007; 27: 2514-2523.
10. Li YH, Shi GY, Wu HL: Thrombomodulin in the treatment of atherothrombotic diseases. Front Biosci (Schol Ed) 2009; 1: 33-38.
11. Preissner KT, Reuning U: Vitronectin in vascular context: facets of a multitalented matricellular protein. Semin Thromb Hemost 2011; 37: 408-424.
12. Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E, ENHANCE investigators: Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-1443.
13. Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M: Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med 2009; 361: 2113-2122.
14. http://www.clinicaltrials.gov/ct2/results?term=improve+it (accessed November 21, 2012).